Cargando…
ARHGAP44-mediated regulation of the p53/C-myc/Cyclin D1 pathway in modulating the malignant biological behavior of osteosarcoma cells
OBJECTIVE: Osteosarcoma is a rare primary malignant tumor of the bone characterized by poor survival rates, owing to its unclear pathogenesis. Rho GTPase-activating protein 44 (ARHGAP44), which belongs to the Rho GTPase-activating protein family, has promising applications in the targeted therapy of...
Autores principales: | Li, Shizhe, Xue, Jiancheng, Zhang, He, Shang, Guanning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688487/ https://www.ncbi.nlm.nih.gov/pubmed/38031136 http://dx.doi.org/10.1186/s13018-023-04406-z |
Ejemplares similares
-
Notch-1 promotes the malignant progression of osteosarcoma through the activation of cell division cycle 20
por: Gao, Yuan, et al.
Publicado: (2020) -
[Retracted] Ursolic acid suppresses the biological function of osteosarcoma cells
por: Pei, Yi, et al.
Publicado: (2023) -
Immunoexpression of Ki67, p53 and cyclin D1 in osteosarcomas
por: Niculescu, Ştefan Adrian, et al.
Publicado: (2021) -
The Roles of Noncoding RNAs in the Development of Osteosarcoma Stem Cells and Potential Therapeutic Targets
por: Liu, Jinxin, et al.
Publicado: (2022) -
TP53 in Biology and Treatment of Osteosarcoma
por: Synoradzki, Kamil Jozef, et al.
Publicado: (2021)